ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2026
Early Gestational Diabetes Mellitus: A Need for Better Understanding and Wise Navigation.
Article in Diabetes therapy : research, treatment and education of diabetes and related disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Early diagnosis of gestational diabetes mellitus evidence from Asia countries: A meta-analysis and systematic review.Journal of diabetes investigation · 2026Article
- A prospective cohort study comparing IADPSG and DIPSI criteria for diagnosing gestational diabetes and evaluating impact on maternal and neonatal health outcomes (DECIDE study protocol).BMC pregnancy and childbirth · 2026Observational
- Enhancing expertise in management of gestational diabetes mellitus: protocol for development of structured curriculum.BMC pregnancy and childbirth · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Early gestational diabetes mellitus (eGDM) is a condition identified during early pregnancy, characterized by glucose levels that are neither normal nor high enough to meet the criteria for overt diabetes. eGDM is associated with adverse pregnancy and postpartum outcomes, but owing to its heterogeneity, management remains challenging. Women with eGDM can be categorized into distinct phenotypes: mild, moderate, and severe, based on glycemic levels, response to behavioral interventions, and associated risk factors. Additionally, some women with eGDM regress to normoglycemia, while others with early normoglycemia may develop gestational diabetes later ("potential GDM"). Precision medicine offers a tailored approach to managing eGDM, emphasizing individualized treatment plans to optimize outcomes and minimize harm. Future research should focus on refining diagnostic criteria, identifying phenotypes early, and implementing personalized management strategies. This commentary highlights the need for a nuanced understanding of eGDM to improve maternal and neonatal health.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.